743938
Last Update Posted: 2015-10-12
Recruiting has ended
All Genders accepted | 18 Years + |
141 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC
The purpose of this study is to improve disease control and survival for patients who were treated with chemotherapy using BMS-690514 over erlotinib
Eligibility
Relevant conditions:
Non Small Cell Lung Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov